Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder - Wikidata - awgldk - TriplyDB

Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder

Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder

http://www.wikidata.org/entity/Q35954857

about

Are Motivation Deficits Underestimated in Patients With ADHD? A Review of the Literature The cognition-enhancing effects of psychostimulants involve direct action in the prefrontal cortex Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of harmful effects in non-randomised studies Common and distinct neural targets of treatment: changing brain function in substance addiction Neuroimaging of attention-deficit/hyperactivity disorder: current neuroscience-informed perspectives for clinicians Dopamine receptor activation increases HIV entry into primary human macrophages Methylphenidate enhances executive function and optimizes prefrontal function in both health and cocaine addiction Effects of stimulants on brain function in attention-deficit/hyperactivity disorder: a systematic review and meta-analysis.Imaging functional and structural brain connectomics in attention-deficit/hyperactivity disorder.Imaging the ADHD brain: disorder-specificity, medication effects and clinical translation.The brain anatomy of attention-deficit/hyperactivity disorder in young adults - a magnetic resonance imaging study.Magnetization transfer imaging identifies basal ganglia abnormalities in adult ADHD that are invisible to conventional T1 weighted voxel-based morphometry.Reward modulation of cognitive function in adult attention-deficit/hyperactivity disorder: a pilot study on the role of striatal dopamine Methylphenidate does not influence smoking-reinforced responding or attentional performance in adult smokers with and without attention deficit hyperactivity disorder (ADHD).Prioritization of candidate genes for attention deficit hyperactivity disorder by computational analysis of multiple data sources.Attention-deficit/hyperactivity disorder treatment: what are the long-term cardiovascular risks?ADHD & Pharmacotherapy: Past, Present and Future: A Review of the Changing Landscape of Drug Therapy for Attention Deficit Hyperactivity Disorder Long-term stimulant treatment affects brain dopamine transporter level in patients with attention deficit hyperactive disorder Elevated background noise in adult attention deficit hyperactivity disorder is associated with inattention Performance enhancement in the workplace: why and when healthy individuals should disclose their reliance on pharmaceutical cognitive enhancers.Dissociable rate-dependent effects of oral methylphenidate on impulsivity and D2/3 receptor availability in the striatum.Effect of brain structure and function on reward anticipation in children and adults with attention deficit hyperactivity disorder combined subtype.Moral and social reasons to acknowledge the use of cognitive enhancers in competitive-selective contexts.Diagnosis of children's attention deficit hyperactivity disorder (ADHD) and its association with cytomegalovirus infection with ADHD: a historical review Evidence that sleep deprivation downregulates dopamine D2R in ventral striatum in the human brain.Chronic treatment with extended release methylphenidate does not alter dopamine systems or increase vulnerability for cocaine self-administration: a study in nonhuman primates Prescription stimulants in individuals with and without attention deficit hyperactivity disorder: misuse, cognitive impact, and adverse effects.The norepinephrine transporter in attention-deficit/hyperactivity disorder investigated with positron emission tomography.Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication.Just How Cognitive Is "Cognitive Enhancement"? On the Significance of Emotions in University Students' Experiences with Study Drugs Differential effects of methylphenidate and cocaine on GABA transmission in sensory thalamic nuclei.Working memory capacity predicts effects of methylphenidate on reversal learning Executive cognitive dysfunction and ADHD in cocaine dependence: searching for a common cognitive endophenotype for addictive disorders Pharmacotherapy of traumatic brain injury: state of the science and the road forward: report of the Department of Defense Neurotrauma Pharmacology Workgroup.Dopamine release from the locus coeruleus to the dorsal hippocampus promotes spatial learning and memory.Age-Dependent Effects of Methylphenidate on the Human Dopaminergic System in Young vs Adult Patients With Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial.Sleep-Dependent Consolidation of Rewarded Behavior Is Diminished in Children with Attention Deficit Hyperactivity Disorder and a Comorbid Disorder of Social Behavior.Adult attention deficit hyperactivity disorder: translating research into practice.Emerging association between addictive gaming and attention-deficit/hyperactivity disorder.Brain γ-aminobutyric acid: a neglected role in impulsivity.

P2860

Q22241207-5BAC25D6-15A1-41C0-B1A0-6DFD0E061220 Q22252343-BFB1DEFA-0057-490A-A14A-867F2BCDF623 Q24186221-74619CA9-EC23-4EE6-994B-692A33D7F8F7 Q27027961-30555E2A-5544-420A-9B49-589E7B30E630 Q28272246-DF1F7A2A-4797-4296-B885-3182F6EBE578 Q28543414-84D8BF57-6504-46A6-B4BA-E3DED38F33FD Q30417580-0DB22AAF-781E-4CA7-BB78-2A63009A4B91 Q30710211-ADD42139-1224-4AE2-AC9E-245C848254D6 Q30794696-23B7B8AD-F73E-4FAB-ACA4-2B831D8B68EA Q30802491-DC7A2203-CCFE-421B-B180-6E128DD33BD1 Q33562735-F84EE0A7-379C-46C2-A0A6-B4AFD428386F Q33580182-F1EB0671-B320-455B-A4B0-2C6B3CF419C0 Q33583802-CDAB4A8A-14EC-44EE-B201-9C6CD86A8B37 Q34092586-8086E8E5-9E3B-4958-A511-F26395469A68 Q34330634-5AD38D96-C8C5-4361-9080-E2084692EBC1 Q34461113-952FA429-FAC7-4319-904E-C74F85DF44EA Q34493964-ABE13BB5-5D2A-4CA7-BC2B-A1CBC5CE5F7C Q34733657-90B30DDD-EFEC-4A3C-B1D2-01DB8827A2DC Q35097156-66E06D70-3930-4299-95CF-1858B2D64283 Q35120607-3B463359-1003-4F31-B172-3EFE06AF396A Q35142888-2C23FE9F-184C-489B-8FD6-3FB17886D991 Q35790441-D24F9206-832E-4F34-B766-E91271CFDB00 Q35973078-8C0C7982-088E-4A1A-81F8-4A534F67ACB7 Q36183375-8A33A61F-7999-42CB-8180-20A2E93AC69F Q36206973-ADF865B3-F8A7-4403-BBDA-8312F72E417A Q36323506-20030E19-B3B8-40DB-A214-2D6B4A90813E Q36373539-9A551F5A-A2D3-4F62-9FE6-1465F9BA5D93 Q36424492-C13AB2C1-C45A-46E6-9017-0D16360694C0 Q36659092-4B29F732-A8C2-41C2-988F-ABD2F49B9703 Q36663548-57D3CDD3-8703-4776-AA4C-5F4DFB40EA17 Q36900796-836F0FE4-4E18-47F7-9CF3-C7B3585F50AA Q37103313-136457AF-B1EA-4C98-BB24-94EDD542DAC8 Q37240922-F18FA43A-7CA3-423E-A844-7AB635EB40E0 Q37508249-7CD26652-C49F-46A7-A21C-0B86161804F5 Q37534434-78EB9A10-05E4-4178-868D-2390E0ECB532 Q37607582-448ECC64-C848-4AE3-93E4-3170122C93B0 Q37629818-09863F65-8878-4A37-87C3-8B504ABE2BFD Q37986704-16391469-8765-484D-B100-FF6ED23CD39C Q38030488-B17105F9-49C8-4681-8243-C3AD27BCB35C Q38181608-D7092581-C3CE-4691-BDA2-6F4B54B41FB4

P2860

Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder

http://www.wikidata.org/entity/Q35954857

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Methylphenidate-elicited dopam ...... deficit hyperactivity disorder

@ast

Methylphenidate-elicited dopam ...... deficit hyperactivity disorder

@en

type

label

Methylphenidate-elicited dopam ...... deficit hyperactivity disorder

@ast

Methylphenidate-elicited dopam ...... deficit hyperactivity disorder

@en

prefLabel

Methylphenidate-elicited dopam ...... deficit hyperactivity disorder

@ast

Methylphenidate-elicited dopam ...... deficit hyperactivity disorder

@en

P1433

Q35954857-FDD6DAA0-85E0-49FA-9FDA-DF128B727625

P1476

Q35954857-F1FAE0E1-5DE2-4999-82E7-1374592851B2

P2093

Q35954857-0EBC712E-1380-4107-B4DC-78B6DFD8AFBB

Q35954857-3BE53E8E-C165-48E2-9C43-6969F227BFFE

Q35954857-5BC10590-22EE-4E1C-91EA-55FFAD020089

Q35954857-5C2EC150-0F02-4CE4-990B-72DF50D466EE

Q35954857-6063CAA7-1242-4F2D-AC40-142F122A62F0

Q35954857-91967772-15D4-4205-9517-030DCC01B8B5

Q35954857-9ECD26DE-2978-4001-8BDD-C1746CC8CCFF

Q35954857-A4C0392E-C436-44CB-851E-E1F21F7EC5EE

Q35954857-ECFF9263-2526-46E0-98A5-FCDA89A5C028

Q35954857-EE59D395-399A-42D0-A893-171E2F2D369D

P2860

Q35954857-0ADDD5DE-C906-4D5B-B0F9-D3B6C36890C3

Q35954857-116319EB-39D0-45A5-A5B3-F26EE2705BF2

Q35954857-11B88861-E16C-498E-A258-56075B91DD9B

Q35954857-25C0C93E-FCFF-441D-9E40-DFA065223448

Q35954857-280E4E1F-979C-45CD-A2F9-DB875ABC3758

Q35954857-2CD215C0-C8F5-4EEB-8C3E-C072E5F58707

Q35954857-31AD67C2-C5A3-448C-9148-1DFD342D1470

Q35954857-409796D1-0F5B-4760-91A8-342ACE2FD484

Q35954857-41EB3B8A-5B7E-4897-B687-D8DA1CB2549F

Q35954857-43012BC9-5F7D-4289-A178-9B60ACD1FD06

P304

Q35954857-D52EFE54-09F8-455B-8839-2213B06A3335

P31

Q35954857-D937DC19-0F89-4F36-BB12-2B7FE4C0F85B

P356

Q35954857-E828A852-3D88-45DF-AECD-556C5D6A81B3

P407

Q35954857-1AE84EF1-39F9-4525-A93E-A3849FA3F7C2

P433

Q35954857-2627427A-2D42-4929-934B-6D48E312CAF2

P478

Q35954857-3408B0CC-D71E-4A31-976C-C9D63BDEF6BD

P577

Q35954857-D8B49C98-6B46-41E3-B491-42B439220F29

P5875

Q35954857-07A696ED-5E77-4B3A-9AED-6EE30C6E0E3E

P698

Q35954857-C1A471B4-DBA0-4AF2-8653-0A2539D25592

P921

Q35954857-44205526-8D6F-4FAB-ADE9-FE3EC9C6A86B

Q35954857-B3DC74C2-C131-4A28-86FE-797771916ABF

P932

Q35954857-ED6A66C3-7ED5-48A3-ABC6-2A5934A6F601

P356

JNEUROSCI.4461-11.2012

P1433

Journal of Neuroscience

P1476

Methylphenidate-elicited dopam ...... deficit hyperactivity disorder

@en

P2093

Christopher T Wong

http://www.w3.org/2001/XMLSchema#string

Dardo Tomasi

http://www.w3.org/2001/XMLSchema#string

Frank W Telang

http://www.w3.org/2001/XMLSchema#string

Gene-Jack Wang

http://www.w3.org/2001/XMLSchema#string

James M Swanson

http://www.w3.org/2001/XMLSchema#string

Jean Logan

http://www.w3.org/2001/XMLSchema#string

Jeffrey H Newcorn

http://www.w3.org/2001/XMLSchema#string

Joanna S Fowler

http://www.w3.org/2001/XMLSchema#string

Nora D Volkow

http://www.w3.org/2001/XMLSchema#string

Scott H Kollins

http://www.w3.org/2001/XMLSchema#string

P2860

The MTA at 8 Years: Prospective Follow-up of Children Treated for Combined-Type ADHD in a Multisite Study

Evaluating dopamine reward pathway in ADHD: clinical implications

A rating scale for depression

The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication

Brain reward circuitry: insights from unsensed incentives

Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines

The activation of attentional networks

Single- and multiple-dose pharmacokinetics of an oral once-a-day osmotic controlled-release OROS (methylphenidate HCl) formulation

The assessment of anxiety states by rating

Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain.

P304

841-849

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1523/JNEUROSCI.4461-11.2012

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221764387

http://www.w3.org/2001/XMLSchema#string

P698

22262882

http://www.w3.org/2001/XMLSchema#string

P921

corpus striatum

P932

3350870

http://www.w3.org/2001/XMLSchema#string